Discovery of potentially biased agonists of mu-opioid receptor (MOR) through molecular docking, pharmacophore modeling, and MD simulation
Discovery of potentially biased agonists of mu-opioid receptor (MOR) through molecular docking, pharmacophore modeling, and MD simulation
复制标题
通过分子对接、药效团建模和 MD 模拟发现潜在偏向的 mu-阿片受体 (MOR) 激动剂
DOI:
10.1016/j.compbiolchem.2020.107405
复制
发表时间:
2021-02-02
影响因子:
3.1
通讯作者:
Wang, Liang-Liang
中科院分区:
文献类型:
--
作者:
Jiang, Xuan;Li, Shuxiang;Wang, Liang-Liang
Opioids are well known for their potent analgesic efficacy and severe side effects. Studies have shown that analgesic effects are mediated by the downstream G-protein-dependent pathway of the mu-opioid receptor (MOR), and another beta-arrestin-dependent pathway mediates side effects such as respiratory depression, constipation and tolerance etc. TRV130 is a biased ligand for G-protein-dependent pathway, which has high analgesia and has fewer side effects than morphine. In this study, the structure similarity search was performed on the IBSSC database using Oliceridine (TRV130) and PZM21 as templates. The 3D structure-based pharmacophore model was built and combined molecular docking prediction mode was selected to filter out small molecules, Finally, based on affinity prediction, four candidate molecules were obtained. Molecular dynamics simulations explored the detailed interaction mechanism of proteins with small molecules under dynamics. These results suggest that these candidate molecules are potential MOR agonists.